A 33-year-old woman hears brutal and frightening voices daily but continues her college studies. A middle-aged man, who served in the Navy and has since struggled with substance ...

Discover how schizophrenia affects work life, and explore strategies for obtaining work accommodations, establishing support, ...

Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

New guidelines have been developed for the treatment of schizophrenia after a collaboration of international experts from 30 ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.

BPD is characterized by extreme emotional dysregulation, whereas schizophrenia mainly involves a disconnect from reality ...

Antipsychotic drugs are the primary treatment for psychotic disorders. These medications can reduce psychosis symptoms in people with mental health conditions such as schizophrenia. However ...

Recent onset of schizophrenia or other primary psychotic disorders may need intensive support for lives disrupted by their diagnosis.

Washingtonians with schizophrenia are curious about a recently FDA-approved drug to treat their symptoms but much is unknown about how well it works.